title: Local control of hepatic phenotype with growth factor-encoded surfaces.
abstract: The goal of the present study was to modulate the phenotype expression of hepatocytes in vitro on surfaces imprinted with growth factors (GFs). Hepatocyte growth factor (HGF) or transforming-growth factor-β1 (TGF-β1) were mixed with collagen (I) and robotically printed onto standard glass slides to create arrays of 300 μm or 500 μm diameter spots. Primary rat hepatocytes were seeded on top of the arrays, forming clusters corresponding in size to the underlying protein spots. The TGF-β1 spots appeared to downregulate markers of hepatic (epithelial) phenotype while upregulating expression of mesenchymal markers. Conversely, hepatocytes cultured on HGF spots maintained high level of epithelial markers. When hepatocytes were seeded onto alternating spots of HGF and TGF-β1, their phenotype was found to depend on center-to-center distance between the spots. At shorter distances cross-expression of epithelial and mesenchymal markers was observed while at distances exceeding 1.25 mm divergence of phenotypes, epithelial on HGF and mesenchymal on TGF-β was seen. Overall, our results demonstrate that GF-encoded surfaces can modulate phenotype within groups of cells cultured on the same surface. Given the importance of phenotype switching in development, fibrosis and cancer, this platform may be used to gain useful insights into the mechanisms of processes such as epithelial-to-mesenchymal transition or stem cell fate selections.
authors.affiliation: Department of Biomedical Engineering, University of California, Davis, 451 East Health Sciences St. #2619, Davis, CA, USA. arevzin@ucdavis.edu.
authors.forename: Dipali
authors.initials: D
authors.lastname: Patel
authors.forename: Amranul
authors.initials: A
authors.lastname: Haque
authors.forename: Caroline N
authors.initials: CN
authors.lastname: Jones
authors.forename: Nazgul
authors.initials: N
authors.lastname: Tuleouva
authors.forename: Elena
authors.initials: E
authors.lastname: Foster
authors.forename: Tam
authors.initials: T
authors.lastname: Vu
authors.forename: A Hari
authors.initials: AH
authors.lastname: Reddi
authors.forename: Alexander
authors.initials: A
authors.lastname: Revzin
mesh_terms: D000818:Animals; D001549:Benzamides / Q000494:pharmacology; D015153:Blotting, Western; D002454:Cell Differentiation / Q000502:physiology*; D004149:Dioxoles / Q000494:pharmacology; D005260:Female; D017228:Hepatocyte Growth Factor / Q000037:antagonists & inhibitors / Q000378:metabolism*; D022781:Hepatocytes / Q000166:cytology / Q000378:metabolism* / Q000648:ultrastructure; D007150:Immunohistochemistry; D007211:Indoles / Q000494:pharmacology; D008099:Liver / Q000166:cytology / Q000378:metabolism*; D008856:Microscopy, Fluorescence; D010641:Phenotype; D010879:Piperazines / Q000494:pharmacology; D051381:Rats; D011917:Rats, Inbred Lew; D015398:Signal Transduction / Q000502:physiology*; D013449:Sulfonamides / Q000494:pharmacology; D053773:Transforming Growth Factor beta1 / Q000037:antagonists & inhibitors / Q000378:metabolism*
chemical_list: C478479:((3Z)-N-(3-chlorophenyl)-3-((3,5-dimethyl-4-((4-methylpiperazin-1-yl)carbonyl)-1H-pyrrol-2-yl)methylene)-N-methyl-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide); C459179:4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide; D001549:Benzamides; D004149:Dioxoles; D007211:Indoles; D010879:Piperazines; D013449:Sulfonamides; D053773:Transforming Growth Factor beta1; D017228:Hepatocyte Growth Factor